Financhill
Sell
26

SAGE Quote, Financials, Valuation and Earnings

Last price:
$6.39
Seasonality move :
-1.48%
Day range:
$6.58 - $6.80
52-week range:
$4.62 - $13.47
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
8.53x
P/B ratio:
1.01x
Volume:
877.9K
Avg. volume:
1.1M
1-year change:
-45.66%
Market cap:
$413.9M
Revenue:
$41.2M
EPS (TTM):
-$5.80

SAGE Analysts' Consensus Rating

The 15 analysts providing 12-month price projections for Sage Therapeutics shares anticipate an average target of $8.21, ranging from a low estimate of $5.00 to a high estimate of $12.00. This average target implies a growth of 24.25% compared to the current stock price of $6.61.

Consensus Price Target

$8.21

Highest Price Target

$12.00

Lowest Price Target

$5.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 0 0 0

Hold 17 15 15

Sell 0 0 0
Consensus Hold Hold Hold

SAGE Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Stocks Are Recession-Proof?
What Stocks Are Recession-Proof?

Fears of a recession prevailed in Q2 2025 when the…

Which Stocks Are Recession-Proof?
Which Stocks Are Recession-Proof?

Fears of a recession prevailed in Q2 2025 when the…

Is Gartner a Safe Stock to Own?
Is Gartner a Safe Stock to Own?

Gartner (NYSE:IT) is among the world’s largest consulting, research and…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 38x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
70
Is NVDA Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 44x

Alerts

Buy
57
RGC alert for May 14

Regencell Bioscience Holdings [RGC] is up 8.9% over the past day.

Buy
54
HALO alert for May 14

Halozyme Therapeutics [HALO] is down 4.72% over the past day.

Buy
91
COIN alert for May 14

Coinbase Global [COIN] is up 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock